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I. Introduction 
a. KCNQ channel family 
 The KCNQ family is composed of a wide variety of voltage-gated potassium channel 
proteins that have pleiotropic effects throughout the body. These effects range from regulating 
potassium currents in the heart to regulating neuronal excitability. While this project is focused 
on KCNQ2, it is important to understand the functions of the KCNQ family in general. All of 
these channels have six transmembrane domains and a single P-loop. The P-loop is the portion of 
the protein that contains the K+ specific pore, characterized by the sequence TxxTxGYG. The S4 
transmembrane domain forms the voltage sensor of these channels. All KCNQ subunit families 
have six positively charged amino acids in their S4 region, with the exception of KCNQ1 which 
has four. KCNQ1 channels contain a glycosylation site, and PKA phosphorylation sites have 
been found on KCNQ1 and KCNQ2 (Robbins. 2001). 
KCNQ1 plays an important role in the heart, inner ear, and intestine. In the heart, it is 
involved in regulating inward rectifying potassium currents. It can co-assemble with KCNE1 and 
KCNE3. Complexing with the KCNE1 forms the delayed outward rectifier current. On the other 
hand, co-assembly with KCNE3 forms a channel that is open all the time, and it is thought that 
the KCNQ1/KCNE3 complex is involved in a cAMP-mediated potassium current in colonic 
crypt cells (Robbins. 2001). The KCNQ1 current activates rapidly; there is fast removal of 
inactivation and slow inactivation. This allows the channels to open again before they are 
deactivated (Tristani-Firouzi & Sanguinetti, 1998). KCNQ1 is involved in Long QT Syndrome, a 
condition where ventricular repolarization is impaired due to mutations in KCNQ1.  
KCNQ2 is a neuronal potassium channel. In conjunction with KCNQ3, it forms a 
heteromultimeric channel unique from KCNQ2 or KCNQ3 channels alone. KCNQ2/KCNQ3 
heteromultimers cause an increased expression of functional channels at the cell membrane, 
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which produces currents much larger than homomultimers (Schwake et al., 2000). 
KCNQ2/KCNQ3 heteromultimeric channels are known as the M-channel and mediate the M-
current (Yang, et al. 1998, Cooper et al. 2000). In addition to interacting with KCNQ2, KCNQ3 
channels interact with the entire KCNQ family, except for KCNQ1. It is the most promiscuous 
out of all the KCNQ channels, whether it exists as a functional homomeric channel remains 
unknown. KCNQ3 channels are outward rectifiers at positive voltages, following currents get 
smaller, even though voltage and driving force for K+ ions are increasing and show sigmoidal 
activation.  
KCNQ4 channels play an important role in hearing and balance. They are found within 
cochlear outer hair cells and auditory system neurons and form a homotetrameric channel or co-
assemble with KCNQ3 to form a heterotetrametric potassium channel. It is involved in the 
potassium current that regulates the excitability of cochlear cells. Mutations in KCNQ4 are 
associated with deafness (Gene Database).  
KCNQ5 may also play a role in mediating the M-current. It is expressed in the brain and 
skeletal muscle and co-assembles with KCNQ3. Similar to KCNQ3, it also has outward rectifier 
currents. Its kinetics are similar to the M-current, which further suggests that it may play a role in 
its mediation (Schroeder et al., 2000). In addition to its possible M-current function, it may also 
play a role in skeletal muscle function.  
 
b. KCNQ2 localization 
KCNQ2 is expressed widely throughout the brain. Its expression is most high in the 
hippocampus, caudate nucleus, amygdala, and cerebral cortex. It is moderately expressed in the 
thalamus, putamen, temporal lobe, frontal lobe, occipital pole, and cerebellum. KCNQ2 shows 
weak expression in the subthalamic nucleus, substantia nigra, and corpus callosum. KCNQ2 and 
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KCNQ3 have nearly identical expression patterns in the brain, likely due to their involvement in 
the formation of the M-channel. (Yang, et al. 1998). 
 
c. KCNQ2 subcellular localization 
KCNQ2 is present in multiple subcellular locations. It has been shown to be expressed 
dendritically and somatically in the hippocampus and cerebral cortex, as well as postsynaptically, 
through immunohistochemistry. Somatodendritic staining has specifically been detected in CA3 
pyramidal cells, granule cells, mossy cells, hippocampal formation, and hilar polymorphic cells.  
KCNQ2 channels have been found to be expressed on mossy fiber bundles-- the axons of 
excitatory granule cells. KCNQ2 is also found in neuropils (a network of unmyelinated axons) of 
the inner dentate molecular layer (Cooper et al. 2000).  
Functional KCNQ2 channels are additionally found in the Nodes of Ranvier. This was 
discovered through the immunolabeling of adult rat sciatic nerves. KCNQ2 channels were found 
to be co-stained with Nav channel α subunits, another nodal marker. In addition to PNS nodes, 
KCNQ2 was also found to be co-localized with Nav channels on CNS nodes via immunolabeling 
of the rat spinal cord. It was also found to be located in axon initial segments co-localized with 
ankyrin G or Nav channels. It is worth noting that KCNQ3 and KCNQ2 are not co-localized at 
the nodes in peripheral nerves. KCNQ3 is instead co-localized with E-cadherins in the outer 
mesaxon of myelin sheaths and in paranodes in the PNS. KCNQ3 was also not seen in cell 
bodies or axon initial segments in the spinal cord, although some were indeed found at the nodes. 
KCNQ2 and KCNQ3 were found to be co-localized in the axon initial segments of CA1 and 
CA3 pyramidal neurons, in addition to the temporal neocortex. All KCNQ3 positive axon initial 
segments were also positive for KCNQ2 (Devaux et al. 2004).  
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d. KCNQ2 functional properties 
 KCNQ2 plays an important role in mediating the M-current, a slow hyperpolarizing 
potassium current that activates slowly with depolarization (Yang et al.1998). This current plays 
a role in determining the subthreshold electrical excitability of neurons. In conjunction with 
KCNQ3, KCNQ2 forms the M-channel (Cooper et al. 2000). M-channel currents are distinct 
from KCNQ2 or KCNQ3 currents. They are activated at more positive voltages and do not 
rectify, unlike KCNQ2 and KCNQ3 currents (Yang, et al. 1998). M-channel current amplitudes 
are fifteen times greater than in either of its independent subunit channels (Schroeder, et 
al.1998). The M-channel is activated by the cAMP-dependent PKA and is inhibited by GPCR 
activation. cAMP has been shown to increase KCNQ2/KCNQ3 currents due to the PKA 
phosphorylation site on KCNQ2.  
 
e. KCNQ2 biophysical properties 
 KCNQ2 has a N-terminal cAMP-dependent PKA phosphorylation site. Increases in 
cAMP have been shown to enhance KCNQ2 currents, while mutations that eliminated the PKA 
phosphorylation site of KCNQ2 have been shown to decrease current stimulation. This shows 
that cAMP activates KCNQ2/KCNQ3 channels via PKA (Schroeder, Kubisch, Stein, et al. 
1998).  
KCNQ channels all contain four voltage sensing domains (VSDs) and one central pore-
gate domain (PGD). Each Kv-𝛼 subunit contains six transmembrane segments, and assembly of 
four Kv-𝛼 subunits forms the KCNQ channel. The S1-S4 segments of each Kv-𝛼 subunit forms 
the voltage-sensing domain, while the S5-S6 segments form the pore-gate domain. Voltage-
dependent ion channel gating is contingent on activation of the voltage sensing domain due to 
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changes in membrane voltage in addition to pore-gate domain opening and coupling of the VSD 
and PGD (Zaydman and Cui, 2014). PIP2, a second messenger, mediates the coupling of these 
two domains in Kv7 channels and regulates the activity of KCNQ currents. It is required for 
opening of the pore-gate domain as well as for the activation of the voltage sensing domain 
(Zaydman et al. 2013). PIP2 requirement KCNQ2 channel opening is emphasized by a study 
conducted in 2003 which found that all members of the KCNQ family are activated by PIP2, 
including heterodimers of human KCNQ2 and rat KCNQ3 (Zhang et al. 2003). KCNQ currents 
can be inhibited by decreasing the amount of available PIP2 in the membrane through 
phospholipase C activation, activation of lipid phosphatases, and inhibition of PIP kinases (Suh 
and Hille, 2002; Suh et al. 2006; Zhang et al. 2003). PIP2 remains necessary to maintain KCNQ2 
currents, as well as the currents for the entire KCNQ family.  
 
f. KCNQ2 pathology 
There are various unique pathologies that can occur as a result of KCNQ2 channel 
mutations. Benign familial neonatal epilepsy (BFNE) is a seizure disorder that can arise from 
KCNQ2 allele haploinsufficiency, which has loss of function (LOF) effects. It is classified by 
various types of seizures that begin two to eight days after birth and then disappear anywhere 
between their first month of life up until twelve months after birth (Miceli et al. 2018; Berg et al. 
2010). These seizures last only one to two minutes. About ten to fifteen percent of individuals 
who had BFNE as an infant develop epilepsy later on in life (Miceli et al. 2018). Variants that 
cause BFNE are also associated with early-onset encephalopathy. Neonatal epileptic 
encephalopathy (NEE) is a seizure disorder that is characterized by multiple seizures that occur 
every day, starting the first week an infant is born and eventually subside anywhere between nine 
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months and four years. There are significant developmental deficits in individuals that have 
neonatal epileptic encephalopathy. The types of seizures are similar to those of BFNE except 
EEGs for seizures due to NEE show a burst-suppression EEG. A burst- suppression EEG has 
patterns with discontinuous activity that alternates between periods of high electrical activity and 
periods of no activity. Interestingly enough, this type of pattern is also seen in patients under 
general anesthesia or in comas (Ching et al. 2012).  
BFNE and NEE are both due to KCNQ2 mutations that have loss of function effects. 
Mutations in KCNQ2 or KCNQ3 have been found to have a significant reduction in M-current 
amplitude (Yang et al. 1998). A study examined the effects of various BFNE-related KCNQ2 
mutations. They found that mutations in the pore region of KCNQ2 reduced currents by about 
30-60% and that mutations in KCNQ2/KCNQ3 caused a current reduction of 20-30% 
(Schroeder, Kubisch, Stein, et al. 1998). They predicted that a current loss of about 25% is 
sufficient to cause benign familial neonatal epilepsy.  
KCNQ2 mutations are also associated with peculiar gain of function (GOF) effects. R201 
and R201 are residues that are responsible for forming the voltage-sensing domain in KCNQ2. 
R201C and R201H missense mutation variants have been shown to increase channel opening and 
stabilization of the KCNQ2 channel, which is opposite from what is seen in BFNE and NEE 
(Miceli et al. 2015). The R201 residue in particular was found to stabilize voltage-sensing 
domain states through electrostatic interactions with nearby negatively charged residues (Miceli 
et al. 2015). These variants result in hyperexcitability and have been shown to cause an 
exaggerated startle response, neonatal encephalopathy without seizures, hypo-myelination, and 
developmental delays (Mulkey, et al. 2017). This exaggerated startle response resembles that of 
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hyperekplexia, a genetic condition in which glycine neurotransmission in the spinal cord and 
brainstem is affected (Bode and Lynch, 2014).  
Individuals with hyperekplexia have a normal EEG and no signs of encephalopathy. 
There is a distinct difference between hyperekplexia and KCNQ seizures. Consciousness is not 
lost during a hyperekplexia episode, which is what distinguishes it from an epileptic seizure. 
Glycinergic synapses, as well as glycine neurotransmission, is affected in hyperekplexia. 
Mutations in proteins required for normal glycinergic synapse function have been associated 
with the condition.  
The hyperekplexia-like phenotypes that resulted from the R201C and R201H missense 
mutations may be explained by disrupted glycinergic synapse function and neurotransmission. 
As mentioned previously, KCNQ2 channels have multiple localizations and subcellular 
localizations within the brain, however, their presence in the brainstem remains unknown. This 
project focused on determining if KCNQ2 channels are present in the brainstem—particularly in 
the vagus nerve and hypoglossal nerve, as well as how many glycinergic neurons co-express 
KCNQ2 in the brainstem. Since KCNQ2 is an inhibitory potassium channel, its localization in 
the brainstem as well as co-localization with GlyT2 could show some association with 
hyperekplexia. The results of this project may lead into further investigation surrounding 
KCNQ2 GOF effects on glycine neurotransmission in the brainstem, and whether this may 
contribute to hyperekplexia and other phenotypes.  
 
II. Methods  
All experiments were performed according to the guidelines described in the National Institutes 
of Health Guide for the Care and Use of Laboratory Animals and were approved by the 
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Institutional Animal Care and Use Committee of the University of Connecticut, Storrs (Protocol: 
A16-031). Kristen Springer, a member of the Tzingounis lab, did tissue harvesting. 
a. Immunostaining 
 P30 Kcnq2-flag homozygous mice along with their heterozygous and wild-type 
littermates were used. Mice were deeply anesthetized and transcardially perfused with 1x 
phosphate-buffered saline followed by 2% paraformaldehyde (PFA). Brains were subsequently 
dissected and incubated for one hour in 2% PFA then transferred to 30% w/v sucrose and 
incubated overnight for cryoprotection. They were subsequently frozen using isopentane on dry 
ice. 40-60um coronal brainstem slices were taken using a Leica CM3050S cryostat. Slices were 
transferred to a 24 well plate containing blocking solution (0.5% triton and 5% NGS in 1x PBS) 
and incubated for one hour. Slices were transferred to 500μL of primary antibody dilution 
(mouse anti-Flag M2 [Sigma] 1:1000 and rabbit anti-GlyT2 [Synaptic Systems] 1:300) and 
incubated overnight at 4C. Slices were washed three times for 10 minutes in 1x PBS and 
transferred to 500μL of the secondary antibody dilution (1:500), where they incubated for two 
hours then washed again. Slices were then transferred to slides mounting media containing DAPI 
was added and they were covered with a coverslip. Slides were stored at 4°C.  
 
b. Imaging and Analysis  
Slices were imaged using a Leica SP8 confocal microscope and images were analyzed in 
ImageJ. The brightness of each channel was set to be the same for all slices using ImageJ and are 
shown below:   
FlagQ2: 5-71 
GlyT2: 0-49 
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DAPI: 0-63 
Twenty glycinergic neurons from the left and right portions of the vagus nerve, as well as the 
hypoglossal nerve, were randomly selected to be analyzed on ImageJ. After selecting the 
glycine-positive neurons, channels were split and the average fluorescence intensity of the flag 
channel was measured. Signals below the average fluorescence intensity of the background 
(34.7) were considered negative, while signals above this intensity were considered positive for 
KCNQ2 in the flag homozygous mouse. Background intensity was much more variable for flag 
heterozygous mice. To mediate this, an exclusion criterion was created that included the lowest 
(28) and highest background intensity (35). A signal that fell within this range was considered 
positive, while a neuron with a flag average intensity that fell above or below this range was 
considered to be absent of KCNQ2. The percentage of analyzed glycinergic cells that co-express 
KCNQ2 in the vagus and hypoglossal nerve was determined and subsequently plotted with 
standard error bars. 
 
III. Results 
a. KCNQ2 brainstem localization 
We first aimed to see if KCNQ2 was present in the brainstem through identifying FlagQ2 
positive signals. FlagQ2 are mice in which KCNQ2 channels have 3XFLAG epitope. Coronal 
brainstem slices from FlagQ2 homozygous mice were obtained to examine Flag expression 
through immunostaining. FlagQ2 signals were observed to be highly present in the hypoglossal 
and vagus nerve regions of the brainstem (Fig 1a, Fig 2a).  
After observing KCNQ2 brainstem expression, we wanted to determine whether glycinergic 
neurons in particular expressed KCNQ2. To do this we used GlyT2, a specific glycinergic 
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neuronal marker. GlyT2 is a presynaptic glycine transporter. Using this marker, twenty neurons 
in the vagus nerve and hypoglossal nerve were randomly selected to determine if KCNQ2 was 
co-localized with GlyT2, and thus co-localized on glycinergic cells. We focused on the vagus 
and hypoglossal nerves because FlagQ2 expression seemed to be especially concentrated in these 
brainstem regions. GlyT2 expression is shown in the hypoglossal nerve (Fig 1b) and vagus nerve 
(Fig 2b) of the brainstem, which allowed us to identify glycinergic neurons. GlyT2 and FlagQ2 
co-localization is demonstrated through a composite image of FlagQ2 and GlyT2 channels (Fig 
1c, Fig 2c) in both brainstem regions. Interestingly, KCNQ2/GlyT2 co-localization was greater 
in the hypoglossal nerve than in the vagus nerve (Fig 3b).    
These experiments were repeated in a FlagQ2 heterozygous mouse, although they would 
have ideally been done in a FlagQ2 WT mouse to serve as a control. KCNQ2 expression (Fig 4a) 
and GlyT2 co-localization (Fig 4c) was similarly observed in this mouse but to a lesser extent. 
There was also a difference in expression between the hypoglossal (Fig 4) and vagus nerves (Fig 
5), where the vagus nerve had greater FlagQ2/GlyT2 co-localization (Fig 6b). This expression 
differs from what was observed in the homozygous mouse. Regardless of this difference, through 
repeating the experiment in the heterozygous FlagQ2 mouse we were able to further demonstrate 
KCNQ2 brainstem localization as well as KCNQ2 and GlyT2 co-localization in the hypoglossal 
and vagus nerves. 
FlagQ2 (green) and GlyT2 (magenta) signals are shown below as a result of immunostaining. 
While looking at FlagQ2 expression note that somatic staining is clearly visible, as well as some 
possible nerve fiber staining. This is quite unusual compared to what we typically think of 
KCNQ2’s subcellular localization. While KCNQ2 has various subcellular locations and has been 
shown to be located somatically in the hippocampus, it is most commonly known for its high 
 12 
density at the axon initial segments and Nodes of Ranvier. In the brainstem KCNQ2 appears to 
be nearly entirely somatic, which is an interesting finding.  
A 
 
 
B 
 
 
 
 
C 
 
Figure 1- Determination of KCNQ2 brainstem expression in the hypoglossal nerve of a FlagQ2 
homozygous mouse. A.) FlagQ2 positive expression. B.) GlyT2 positive expression. C.) FlagQ2 
(green) and GlyT2 (magenta) double label. Immunostaining demonstrates KCNQ2 and GlyT2 
co-localization.  
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The immunostaining process was repeated for the vagus nerve of the brainstem. Using the 
cerebral aqueduct as a point of reference, the vagus nerve was analyzed by examining it through 
its left and right sections. Below are images of the left vagus nerve of the FlagQ2 homozygous 
mouse, where KCNQ2 somatic staining (Fig 2a) and KCNQ2/GlyT2 co-localization (Fig 2c) is 
much clearer.  
A 
 
B 
 
C 
 
Figure 2- Determination of KCNQ2 brainstem expression in the left vagus nerve of a FlagQ2 
homozygous mouse. A.) FlagQ2 positive expression shows clear somatic staining. B.) GlyT2 
positive expression, with clear somatic and nuclear staining. C.) Double-labeling FlagQ2 and 
GlyT2 demonstrates co-localization. 
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One thing worth noting of the GlyT2 immunostaining shown in Figure 2b was the strong nuclear 
signals in the soma, which initially appeared to be unusual. GlyT2 typically is located in small 
and large vesicles, endosomes, axons, as well as presynaptic terminals (Nuñez, et al. 2009). It is 
involved in removing glycine from the synaptic cleft. This prevents glycine from over 
stimulating its postsynaptic receptor and causing excessive inhibition, as glycine is an inhibitory 
neurotransmitter. Its expression on the cell surface or on the cell interior, and thus its CNS 
function, depends on various stimuli (Nuñez, et al. 2009). For these reasons, GlyT2 nuclear 
expression may be worth investigating in the future.  
A 
 
B 
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Figure 3- Quantification of KCNQ2/GlyT2 co-expression in brainstem glycinergic cells for the 
FlagQ2 homozygous mouse. A.) Percentage of GlyT2 containing neurons that had a FlagQ2 
positive signal (average fluorescence intensity >34.7) in the left and right portions of the vagus 
nerve. B.) Percentage of FlagQ2 positive signals (average fluorescence intensity >34.7) in the 
hypoglossal nerve and vagus nerve. Included in the determination of these percentages are 
twenty neurons of the left and right portions of the vagus nerve and twenty neurons of the 
hypoglossal nerve, as described in the methodology.  
 
After determining the visual presence of KCNQ2 in the brainstem as well its localization 
on glycinergic neurons, we aimed to quantify the co-expression that we observed. We 
accomplished this by randomly selecting glycinergic neurons marked by the presence of GlyT2 
and determined whether these neurons also expressed KCNQ2. The FlagQ2/GlyT2 ratio was 
then calculated and reported as a percentage. We used this method in particular to ascertain the 
amount of glycine neurons that expressed KCNQ2 in a specific area. This also told us how many 
glycinergic neurons contain KCNQ2 as opposed to just GlyT2, which gave us a measure of the 
extent of co-localization.  
 The presence and quantification of KCNQ2 in the brainstem was also determined through 
the same process for the Flag heterozygous mouse. The FlagQ2 signal has much more 
background here, which made it slightly more difficult to visually observe KCNQ2 localization. 
This required a slightly different approach when it came to analysis. In order to quantify FlagQ2 
positive signals, exclusion criterion was created that accounted for the highest and lowest 
intensity background fluorescence in order to distinguish background from a KCNQ2 signal.  
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A 
 
B 
 
C 
 
Figure 4- Determination of KCNQ2 brainstem expression in the hypoglossal nerve of a FlagQ2 
heterozygous mouse. A.) FlagQ2 positive expression. B.) GlyT2 positive expression. C.) FlagQ2 
(green) and GlyT2 (magenta) double label. Immunostaining demonstrates KCNQ2 and GlyT2 
co-localization.  
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A 
 
B 
 
C 
 
Figure 5- Determination of KCNQ2 brainstem expression in the left vagus nerve of a FlagQ2 
heterozygous mouse. A.) FlagQ2 positive expression. B.) GlyT2 positive expression. C.) GlyT2 
and FlagQ2 composite demonstrating visual co-localization. 
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Following immunostaining of the heterozygous Flag mouse, quantification of KCNQ2 
signals was conducted by examining hypoglossal and vagus nerve specific regions of the 
brainstem. The amount of total KCNQ2+ glycinergic neurons, determined by the exclusion 
criteria outlined in the methodology, was divided by the total number of glycinergic neurons 
analyzed to determine the percentage of FlagQ2 positive neurons in these brainstem regions. The 
percentage of glycinergic neurons that contain a KCNQ2 signal in the heterozygous Flag mouse 
are charted below for the vagus and hypoglossal nerve, respectively.   
 
A 
 
B 
 
Figure 6- Quantification of KCNQ2/GlyT2 co-localization in brainstem glycinergic cells for the 
FlagQ2 heterozygous mouse. A.) Percentage of GlyT2 containing neurons that had a FlagQ2 
positive signal (average fluorescence intensity 28>+<35) in the left and right portions of the 
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vagus nerve. B.) Percentage of FlagQ2 positive signals from GlyT2+ glycinergic cells (average 
fluorescence intensity 28>+<35) in the hypoglossal nerve and vagus nerve. Included in the 
determination of these percentages are twenty neurons of the left and right portions of the vagus 
nerve and twenty neurons of the hypoglossal nerve, as described in the methodology.  
 
After quantification of KCNQ2 signal presence in the vagus and hypoglossal nerve in the 
individual homozygous and heterozygous flag mouse, we aimed to compare these results 
between the two mice. Positive signals determined from the twenty neurons analyzed in the left 
vagus nerve, as well as the twenty neurons analyzed from the right vagus nerve were added. 
These signals were then divided by forty—the total number of vagus nerve neurons we 
examined, to calculate the percentage of the total number of KCNQ2 positive signals in the 
vagus nerve. This was done for both the homozygous and heterozygous Flag mouse and is 
presented below. The percentage for the hypoglossal nerve is the same as what was shown 
previously for each mouse. It was determined by dividing the number of FlagQ2 positive signals 
by the number of glycinergic neurons analyzed, which was twenty.  
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Figure 7- Comparison of KCNQ2/GlyT2 co-localization in brainstem glycinergic cells between 
FlagQ2 homozygous and heterozygous mice. In the homozygous mouse, a KCNQ2 signal was 
determined to be positive if the average fluorescence intensity was >34.7. In the heterozygous 
mouse, KCNQ2 signals were determined to be positive if the average fluorescence intensity was 
less than 35 but greater than 28. Any signals outside this range were considered to be 
background and not counted. KCNQ2 expression varied significantly between Flag homozygous 
and heterozygous mice, as well as in the vagus and hypoglossal nerves. There is a higher density 
of KCNQ2 positive signals in the hypoglossal nerve of the Flag homozygous mouse, while the 
opposite remains true of the heterozygous mouse. There are less KCNQ2 positive signals in the 
heterozygous mouse overall, however, significant co-localization is present in both mice. 
 
b. Limitations 
Brainstem slices were cut in a slightly different anatomical position between the 
heterozygous and homozygous flag mice, which may explain some variability in the results such 
as the difference in co-localization in the hypoglossal nerve and vagus nerve in the heterozygous 
flag mouse. Slices and subsequent data from one mouse were not included because of this. 
Represented data is shown for only two mice, one homozygous for flag and another 
heterozygous for flag, which is another limitation of the study. To confirm the validity of the 
results, more homozygous and heterozygous mice should be used to image more slices from 
multiple mice. Obtaining more slices in general will better ensure that those analyzed are from a 
more similar anatomical area. Wildtype mice should also be used to provide a control. 
Other than increasing the sample size of the mice, the sample size of glycinergic neurons 
analyzed should be increased to obtain the most accurate data. In terms of analysis, the FlagQ2 
signal had a lot of signal background, which at times made it difficult to distinguish a positive 
and negative signal. To mediate this, an exclusion criterion was created that incorporated the 
highest and lowest intensity flag signals as thresholds. Since the flag signal intensity was highly 
variable, these parameters were likely not all-encompassing. We attempted the experiment with 
various secondary antibody dilutions and even attempted using a Q2 antibody, which we found 
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was unreliable. We found that our current experimental setup worked best. Future studies should 
aim to minimize signal background through either testing different secondary antibody dilutions, 
using a more reliable Q2 antibody, or testing different settings on the confocal microscope. 
 
IV. Discussion 
a. KCNQ2 is present in the brainstem 
Our results demonstrate that KCNQ2 is indeed present in the brainstem. Immunostaining 
was conducted by using mice with KCNQ2 tagged to a Flag epitope. As all of the anatomical 
areas examined contained FlagQ2 positive neurons it is safe to say that KCNQ2 is present in the 
brainstem, specifically in the vagus and hypoglossal nerves. Whether KCNQ2 has a wider 
distribution in the brainstem remains to be investigated.  
 
b. Glycinergic neurons express KCNQ2 
Not only do the results of this study show that KCNQ2 is present in the brainstem, but 
also provide compelling evidence that KCNQ2 is co-localized on glycinergic cells in the 
brainstem. For the homozygous FlagQ2 mouse, 58% of analyzed neurons in the vagus nerve 
labeled for GlyT2 were also labeled for FlagQ2-- indicating that KCNQ2 channels are present on 
these neurons. For that same mouse, 90% of glycinergic cells in the hypoglossal nerve were also 
labeled for KCNQ2. In the heterozygous FlagQ2 mouse, 55% and 35% of the neurons analyzed 
in the vagus nerve and hypoglossal nerve, respectively, showed GlyT2 and KCNQ2 co-
localization. The amount of FlagQ2 signal present seemed to vary on the anatomical position cut 
of the coronal section of the slice. Obtaining more slices from more mice may give more insight 
on the overall presence of KCNQ2 in these anatomical regions, as obtaining slices from the 
cryostat can be difficult to standardize. Signals also seemed to differ between the homozygous 
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and heterozygous mouse, as well as the specific nerve of the brainstem examined (Fig 7). There 
was more KCNQ2 and GlyT2 co-localization in the homozygous mouse overall, with the highest 
density of signals being in the hypoglossal nerve. The opposite was observed in the heterozygous 
mouse, where KCNQ2 localization on glycinergic neurons was greatest in the vagus nerve (Fig 
7). These differences may likely be explained by the amount of signal background in the 
heterozygous mouse, which made quantification of KCNQ2 difficult. Further trials may provide 
more clarification on the differences observed here.   
For future studies, an additional method of analysis could be incorporated that involves 
all neurons within a select area being considered instead of just glycinergic neurons. To do so, 
neurons within the vagus and hypoglossal nerve would be counted using the DAPI signal, a 
nuclear marker. These neurons would then be examined to determine how many are FlagQ2 
positive, how many are GlyT2 positive, and how many express both. This method of analysis 
would provide an overall percentage of neurons that express KCNQ2 in the hypoglossal and 
vagus nerves, rather than just how many glycinergic neurons express KCNQ2 in these specific 
regions. This would also tell us the overall percentage of neurons that contain GlyT2 in addition 
to the percentage of neurons that contain both KCNQ2 and GlyT2. The method of analysis of 
this study involved randomly selecting neurons labeled for GlyT2 and determining if there is a 
FlagQ2 positive signal. This additional process will give more insight as to the extent of KCNQ2 
localization on glycinergic neurons and may provide a more comprehensive picture of general 
KCNQ2 brainstem localization from a population perspective by using the DAPI signal.  
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c. Study implications 
As a result of the KCNQ2 and GlyT2 co-localization observed in this study, we can not 
only confirm that KCNQ2 is present in the brainstem but that it is also present on glycinergic 
cells. This localization on brainstem glycinergic neurons may have some implications in 
hyperekplexia, a condition in which glycine neurotransmission is inhibited and glycinergic 
synapses are affected. Specific KCNQ2 mutations, thus, may be involved with some 
hyperekplexia-like phenotypes. GOF mutations that cause KCNQ2 to be overactive will cause 
over-inhibition of glycinergic neurons. Inhibition of glycinergic neurons will cause for less 
glycine to be released onto the synaptic cleft. As glycine is an inhibitory neurotransmitter, this 
will result in less inhibition of postsynaptic neurons, or more excitation. While purely 
speculative, this could be involved in hyperekplexia. Hyperekplexia-like phenotypes that occur 
as a result of KCNQ2 R201C and R201H missense mutations have previously been 
demonstrated and include an exaggerated startle response and neonatal encephalopathy without 
seizures (Mulkey, et al. 2017). These particular phenotypes are quite different from what is 
typically seen in KCNQ2 mutations. Hyperekplexia can be distinguished due to the fact that a 
loss of consciousness is not lost during episodes, as what is typical for epilepsy. Neonatal 
encephalopathy is very commonly associated with seizures and it is particularly interesting that 
this KCNQ2 GOF mutation has not been associated with seizures, which does make its possible 
relationship with hyperekplexia looking into. Now that this study has confirmed that KCNQ2 is 
present on brainstem glycinergic neurons, future studies should aim to investigate how glycine 
neurotransmission in the brainstem is affected by KCNQ2 GOF mutations. It also may be worth 
further investigating the physiology that is affected by KCNQ2 GOF mutations in the brainstem 
and if the resulting phenotypes are indeed related to hyperekplexia or other pathologies.  
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